Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

For the latest in precision medicine, sign up for our monthly newsletter to be among the first to receive
exclusive insights, in-depth market analyses, and expert articles directly to your inbox

A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics

On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Watch Now

Accelerate Protein Screening by Sequencing Protein Barcodes on Platinum®

On-demand webinar presented by Joel McDade, PhD, Sr. Commercial Business Development Manager, Quantum-Si and Bonnie Lun, PhD, Field Application Scientist
Watch Now

Challenges and Strategies for the Application of Omics and Spatial Technologies

A concise report featuring insights from the prominent thought leaders of Omics 2023 and Spatial 2024
Read Now

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
NGS

Specialty Immunoassays Test Menu

Read More
NGS

Comprehensive Adaptive Immune Receptor Profiling for All Immune Sample Types

Read More
Biomarker Discovery & Development

Data-driven biomarker R&D: Current chalenges and strategic opportunities

Read More
Single Cell Genomics & Transcriptomics

Exploiting the spatial dimension: The power of single cell spatial transcriptomics

Read More
NGS

CareDx and Dovetail Genomics to Collaborate on NGS Workflow for Transplant HLA Matching

HLA matching is critical for successful transplants. The two companies hope combining their technologies will improve testing; and therefore, patient outcomes.
Read More
Clinical Diagnostics

WHO Publishes Preferred Product Characteristics for Alzheimer’s Blood Tests

The PPC outlines guidance for the development of blood tests for Alzheimer's, including important considerations to increase accessibility and diversity.
Read More
Diagnostic Development

Imaging Starts Using Brand New Radiotracer from Nuclidium

The radiotracer is the first part of Nuclidium’s proposed ‘theranostic pipeline’ which aims to diagnose, stage, and then treat prostate cancer.
Read More
Biomarker Analysis

Etcembly Partner With University of Surrey to Learn From Long Term Cancer Survivors’ T Cells

The analysis of cancer survivors’ T cell receptors may yield fresh targets for immunotherapies.
Read More
Diagnostic Development

GHR Foundation Commits $15m to C2N Diagnostics for Tau Tangle Pathology Test for Diagnosing, Staging Alzheimer’s Disease

GHR’s total investment in C2N has now broken $50 million since 2020.
Read More
Single Cell Analysis

New Research From Indivumed Tx Highlights Importance of Snap Freezing Tumour Samples in Target Discovery and Cancer Therapy Development

Tumour samples which were frozen after more than ten minutes were significantly different in molecular biology to samples which were frozen in less than 10 minutes.
Read More
Single Cell Analysis

National University of Singapore Unveil Novel Single-Cell RNA Analysis Technique

The novel technique effectively denoises scRNA-seq data by fitting a low-dimensional manifold in the high-dimensional space.
Read More
Biomarker Analysis

Study Analyses Predictive Biomarkers for COVID-19 ICU Patient Mortality

The study from the Federal University of Paraíba, Brazil analyses a series of haematological, biochemical, and inflammatory factors all contribute to the mortality of COVID-19 patients in the ICU.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery